Skip Navigation



eCAM Advance Access published online on July 21, 2004
eCAM, doi:10.1093/ecam/neh026
Copyright © 2004 by the Oxford University Press.
This Article
Right arrow Full Text (PDF) Freely available
Right arrowOA All Versions of this Article:
1/2/145    most recent
neh026v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Kobayashi, H.
Right arrow Articles by Ishii, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobayashi, H.
Right arrow Articles by Ishii, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received April 7, 2004
Accepted May 10, 2004

Review

An Alternative Approach to Atopic Dermatitis: Part II--Summary of Cases and Discussion

Hiromi Kobayashi 1*, Kuniaki Takahashi 2, Nobuyuki Mizuno 1, Haruo Kutsuna 1, Masamitsu Ishii 1

1 Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan
2 Takahashi Dermatology Clinic, Daito City, Osaka, Japan

* To whom correspondence should be addressed. E-mail: hiromik{at}med.osaka-cu.ac.jp.


  Abstract

In the first part of this Review, we presented case-series where Kampo treatment was introduced for those atopic dermatitis (AD) patients who had failed with conventional therapy, in an attempt to prove that there exists a definite subgroup of AD patients for whom Kampo treatment is effective. In this second part, we will first provide the summary of the results for 140 AD patients we treated in 2000. The results suggest that Kampo treatment is effective for more than half of AD patients who fail with conventional therapy. In the Discussion, we will examine the evidential basis for conventional AD therapy and discuss how Kampo treatment should be integrated into the guidelines for AD therapy. We contend that Kampo treatment should be tried before systematic immunosuppressive agents are considered. As each Kampo treatment is highly individualized, it should be regarded more as ‘art’ than technology, and special care should be taken to assess its efficacy in clinical trial.

Keywords: Kampo medicine; atopic dermatitis-eczema; diet; herbal medicine; herbal therapy.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Evid Based Complement Alternat MedHome page
A. Kumar, R. Prasad, N. M. Jogge, S. Bhojraj, S. F. Emerson, and S. Prabakar
Herbex-kid Inhibits Immediate Hypersensitivity Reactions in Mice and Rats
Evid. Based Complement. Altern. Med., September 1, 2008; 5(3): 289 - 294.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
H. Kobayashi, M. Ishii, S. Takeuchi, Y. Tanaka, T. Shintani, A. Yamatodani, T. Kusunoki, and M. Furue
Efficacy and Safety of a Traditional Herbal Medicine, Hochu-ekki-to in the Long-term Management of Kikyo (Delicate Constitution) Patients with Atopic Dermatitis: A 6-month, Multicenter, Double-blind, Randomized, Placebo-controlled Study
Evid. Based Complement. Altern. Med., January 31, 2008; (2008) nen003v1.
[Abstract] [Full Text] [PDF]

Home page
 Evid Based Complement Alternat MedHome page
Y. Hijikata, Y. Miyamae, H. Takatsu, and S. Sentoh
Two Kampo Medicines, Jidabokuippo and Hachimijiogan Alleviate Sprains, Bruises and Arthritis
Evid. Based Complement. Altern. Med., December 1, 2007; 4(4): 463 - 467.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.